tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Revenue

Compare
818 Followers

Immunovant Revenue

Immunovant had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 1.50M, Decreased 0.00%. In the fiscal year ending Mar 31, 2024, Immunovant had annual revenue of 0.00 with ― growth.
Revenue (ttm)
1.50M
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
207
Market Cap
$2.46B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 20240.00
Mar 31, 20230.00
Mar 31, 20220.00
Mar 31, 20210.00
Mar 31, 20200.00
Mar 31, 20190.00
Mar 31, 20180.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis